Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project.
Saved in:
| Title: | Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project. |
|---|---|
| Authors: | Taylor MR; Department of Pediatrics, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA.; Ben Towne Center For Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA., Anderson JR; College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA., Park JR; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Irwin MS; Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Applebaum MA; Department of Pediatrics, University of Chicago, Chicago, Illinois, USA., Pinto NR; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA., Streby K; Department of Hematology/Oncology/BMT, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA., Federico SM; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Rosswog C; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany., Ohira M; Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan., Kao PC; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., London WB; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA., Cash T; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA. |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2025 Nov; Vol. 72 (11), pp. e31968. Date of Electronic Publication: 2025 Aug 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40879138 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Taylor+MR%22">Taylor MR</searchLink>; Department of Pediatrics, Division of Hematology/Oncology, University of Washington, Seattle, Washington, USA.; Ben Towne Center For Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+JR%22">Anderson JR</searchLink>; College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.<br /><searchLink fieldCode="AU" term="%22Park+JR%22">Park JR</searchLink>; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Irwin+MS%22">Irwin MS</searchLink>; Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Applebaum+MA%22">Applebaum MA</searchLink>; Department of Pediatrics, University of Chicago, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Pinto+NR%22">Pinto NR</searchLink>; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Streby+K%22">Streby K</searchLink>; Department of Hematology/Oncology/BMT, Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Federico+SM%22">Federico SM</searchLink>; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Rosswog+C%22">Rosswog C</searchLink>; Department of Experimental Pediatric Oncology, University Children's Hospital of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Ohira+M%22">Ohira M</searchLink>; Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Kao+PC%22">Kao PC</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22London+WB%22">London WB</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Cash+T%22">Cash T</searchLink>; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101186624%22">Pediatric blood & cancer</searchLink> [Pediatr Blood Cancer] 2025 Nov; Vol. 72 (11), pp. e31968. <i>Date of Electronic Publication: </i>2025 Aug 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley%22">John Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101186624 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1545-5017 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215455009%22">15455009 </searchLink><i>NLM ISO Abbreviation: </i>Pediatr Blood Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40879138 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/pbc.31968 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e31968 Titles: – TitleFull: Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Taylor MR – PersonEntity: Name: NameFull: Anderson JR – PersonEntity: Name: NameFull: Park JR – PersonEntity: Name: NameFull: Irwin MS – PersonEntity: Name: NameFull: Applebaum MA – PersonEntity: Name: NameFull: Pinto NR – PersonEntity: Name: NameFull: Streby K – PersonEntity: Name: NameFull: Federico SM – PersonEntity: Name: NameFull: Rosswog C – PersonEntity: Name: NameFull: Ohira M – PersonEntity: Name: NameFull: Kao PC – PersonEntity: Name: NameFull: London WB – PersonEntity: Name: NameFull: Cash T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2025 Nov Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1545-5017 Numbering: – Type: volume Value: 72 – Type: issue Value: 11 Titles: – TitleFull: Pediatric blood & cancer Type: main |
| ResultId | 1 |
